Skip to menu Skip to content Skip to footer

2023

Other Outputs

Emerging and adjunct treatments for common mental health conditions affecting veterans: a rapid evidence assessment

Maguire, Angela M., Soole, Rebecca, Beilby, Hannah, Tabinga, Angeli, Barker, Natalie, Fear, Nicola T., Kenardy, Justin, Tuffaha, Haitham and Khoo, Andrew (2023). Emerging and adjunct treatments for common mental health conditions affecting veterans: a rapid evidence assessment. Canberra, ACT Australia: Commonwealth of Australia.

Emerging and adjunct treatments for common mental health conditions affecting veterans: a rapid evidence assessment

2023

Journal Article

A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies

Modi, Natansh D., Kichenadasse, Ganessan, Hoffmann, Tammy C., Haseloff, Mark, Logan, Jessica M., Veroniki, Areti A., Venchiarutti, Rebecca L., Smit, Amelia K., Tuffaha, Haitham, Jayasekara, Harindra, Manning-Bennet, Arkady, Morton, Erin, McKinnon, Ross A., Rowland, Andrew, Sorich, Michael J. and Hopkins, Ashley M. (2023). A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies. BMC Medicine, 21 (1) 400, 1-9. doi: 10.1186/s12916-023-03113-0

A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies

2023

Conference Publication

Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer

Wang, Yufan, McCarthy, Alexandra L. and Tuffaha, Haitham (2023). Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer. HTAi 2023 Meeting, Adelaide, SA Australia, 24-28 June 2023. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/s0266462323001277

Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer

2023

Journal Article

A narrative review of health status and healthcare delivery in the oil and gas industry: impacts on employees, employers, and local communities

Fox, Jordan L., Gurney, Tiana, Kondalsamy-Chennakesavan, Srinivas, Pols, Thomas A. H., Tuffaha, Haitham, Pak, Anton and McGrail, Matthew (2023). A narrative review of health status and healthcare delivery in the oil and gas industry: impacts on employees, employers, and local communities. Healthcare, 11 (21) 2888, 1-17. doi: 10.3390/healthcare11212888

A narrative review of health status and healthcare delivery in the oil and gas industry: impacts on employees, employers, and local communities

2023

Other Outputs

(November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.

Edmunds, K., Hettiarachchi, R., Teppala, S., Shiksha, A., Madeline, O. and Tuffaha, H. (2023). (November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.

(November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.

2023

Journal Article

Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer

Gough, Madeline, Liu, Cheng, Srinivasan, Bhuvana, Wilkinson, Lisa, Dunk, Louisa, Yang, Yuanhao, Schreiber, Veronika, Tuffaha, Haitham, Kryza, Thomas, Hooper, John D., Lakhani, Sunil R. and Snell, Cameron E. (2023). Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer. Histopathology, 83 (4), 647-656. doi: 10.1111/his.15000

Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer

2023

Other Outputs

(August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.

Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.

(August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.

2023

Other Outputs

(August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.

Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.

(August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.

2023

Other Outputs

(August 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.

Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.

(August 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.

2023

Journal Article

Economic evaluation of exercise interventions for individuals with cancer: a systematic review

Wang, Yufan, McCarthy, Alexandra L., Hayes, Sandra C., Gordon, Louisa G., Chiu, Vivian, Bailey, Tom G., Stewart, Elizabeth and Tuffaha, Haitham (2023). Economic evaluation of exercise interventions for individuals with cancer: a systematic review. Preventive Medicine, 172 107491, 1-8. doi: 10.1016/j.ypmed.2023.107491

Economic evaluation of exercise interventions for individuals with cancer: a systematic review

2023

Conference Publication

Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol of an effectiveness-implementation hybrid (Type 1) randomised trial of a tele-based nurse-led survivorship care intervention (PCEssentials)

Green, Anna, Newton, Robert U., Chambers, Suzanne K., Smith, David P., Tuffaha, Haitham, Galvao, Daniel A., Heathcote, Peter, Patel, Manish, Christie, David, Egger, Sam, Sara, Sally, Heneka, Nicole and Dunn, Jeff (2023). Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol of an effectiveness-implementation hybrid (Type 1) randomised trial of a tele-based nurse-led survivorship care intervention (PCEssentials). 2023 ANZUP Annual Scientific Meeting, Melbourne, VIC, Australia, 9‐11 July 2023. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13976

Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol of an effectiveness-implementation hybrid (Type 1) randomised trial of a tele-based nurse-led survivorship care intervention (PCEssentials)

2023

Journal Article

Tele-dentistry, its trends, scope, and future framework in oral medicine; a scoping review during January 1999 to December 2021

Niknam, Fatemeh, Sharifian, Roxana, Bashiri, Azadeh, Mardani, Maryam, Akbari, Reza, Tuffaha, Haitham, Do, Loc and Bastani, Peivand (2023). Tele-dentistry, its trends, scope, and future framework in oral medicine; a scoping review during January 1999 to December 2021. Archives of Public Health, 81 (1) 104, 1-14. doi: 10.1186/s13690-023-01128-w

Tele-dentistry, its trends, scope, and future framework in oral medicine; a scoping review during January 1999 to December 2021

2023

Journal Article

Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer

Wang, Yufan, McCarthy, Alexandra L and Tuffaha, Haitham (2023). Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer. Supportive Care in Cancer, 31 (7) 391, 391. doi: 10.1007/s00520-023-07819-y

Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer

2023

Conference Publication

HER2 in situ hybridization testing in breast cancer: applying algorithm-assisted assessment to reduce interobserver variability in difficult cases

Gough, Madeline, Liu, Cheng, Srinivasan, Bhuvana, Wilkinson, Lisa, Dunk, Louisa, Yang, Yuanhao, Tuffaha, Haitham, Kryza, Thomas, Hooper, John D., Lakhani, Sunil R. and Snell, Cameron Edward (2023). HER2 in situ hybridization testing in breast cancer: applying algorithm-assisted assessment to reduce interobserver variability in difficult cases. 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.e13561

HER2 in situ hybridization testing in breast cancer: applying algorithm-assisted assessment to reduce interobserver variability in difficult cases

2023

Other Outputs

(April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACT

Hettiarachchi, R. and Tuffaha, H. (2023). (April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACT. Canberra, ACT, Australia: Commonwealth of Australia.

(April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACT

2023

Journal Article

Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway

Delaforce, Alana, Farmer, Shannon, Duff, Jed, Munday, Judy, Miller, Kristin, Glover, Lynne, Corney, Chris, Ansell, Gareth, Gutta, Naadir, Tuffaha, Haitham, Hardy, Janet and Hurst, Cameron (2023). Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway. Transfusion, 63 (4), 724-736. doi: 10.1111/trf.17287

Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway

2023

Journal Article

A review of the cost-effectiveness of genetic testing for germline variants in familial cancer

Teppala, Srinivas, Hodgkinson, Brent, Hayes, Sandi, Scuffham, Paul and Tuffaha, Haitham (2023). A review of the cost-effectiveness of genetic testing for germline variants in familial cancer. Journal of Medical Economics, 26 (1), 19-33. doi: 10.1080/13696998.2022.2152233

A review of the cost-effectiveness of genetic testing for germline variants in familial cancer

2022

Journal Article

Approaches to prioritising research for clinical trial networks: a scoping review

Morton, Rachael L., Tuffaha, Haitham, Blaya-Novakova, Vendula, Spencer, Jenean, Hawley, Carmel M., Peyton, Phil, Higgins, Alisa, Marsh, Julie, Taylor, William J., Huckson, Sue, Sillett, Amy, Schneemann, Kieran, Balagurunanthan, Anitha, Cumpston, Miranda, Scuffham, Paul A., Glasziou, Paul and Simes, Robert J. (2022). Approaches to prioritising research for clinical trial networks: a scoping review. Trials, 23 (1) 1000, 1-21. doi: 10.1186/s13063-022-06928-z

Approaches to prioritising research for clinical trial networks: a scoping review

2022

Conference Publication

How would the choice of the multi-attribute utility instrument affect the cost-effectiveness of cancer interventions? A comparison of the FACT-8D and the AQoL

Tuffaha, H., Arora, S., Denehy, L. and Edbrooke, L. (2022). How would the choice of the multi-attribute utility instrument affect the cost-effectiveness of cancer interventions? A comparison of the FACT-8D and the AQoL. ISPOR Europe 2022, Vienna, Austria, 6-9 November 2022. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2022.09.2001

How would the choice of the multi-attribute utility instrument affect the cost-effectiveness of cancer interventions? A comparison of the FACT-8D and the AQoL

2022

Conference Publication

How would the choice of health-related quality of life measure affect the cost-effectiveness of oncology interventions?

Tuffaha, Haitham, Arora, Shiksha, Denehy, Linda and Edbrooke, Lara (2022). How would the choice of health-related quality of life measure affect the cost-effectiveness of oncology interventions?. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

How would the choice of health-related quality of life measure affect the cost-effectiveness of oncology interventions?